Feature Image

MJNA Mentioned in The Motley Fool’s Guide on MMJ Investing

Medical Marijuana, Inc. is highlighted in the investor advising website’s short guide on investing in marijuana stocks.

The Motley Fool highlighted Medical Marijuana, Inc. (OTC: MJNA) in a new article this week on how to invest and profit in the cannabis industry.

The Motley Fool provides investment and stock advising for individual investors. In its recent article, “The 5-Minute Guide on How to Invest in Marijuana Stocks,” the advising site offers guidance on how investors can profit from the $7 billion cannabis industry. The guide features selective marijuana stocks currently available on the market, including Medical Marijuana, Inc.

Medical Marijuana, Inc. is the first publicly held cannabis company in the medical marijuana and industrial hemp markets in the United States. The company is comprised of a diversified portfolio of subsidiaries and investment holdings that focus on the development, sale, and distribution of hemp oil containing naturally occurring cannabinoids, including cannabidiol (CBD).

The Motley Fool specifically highlighted Medical Marijuana, Inc.’s investment company AXIM® Biotechnologies, an innovative biotechnology company that focuses on the research, development, and production of cannabinoid-based pharmaceuticals and supplements, as well as its CBD hemp oil distribution company HempMeds® and its all-inclusive cannabis business security company MPS International.

The hemp CBD market is expected to grow at a 55% CAGR to reach $1 billion by 2020, according to a recent report from Brightfield Group. As the first company to retail CBD hemp oil products across state lines and to international markets, Medical Marijuana, Inc. has positioned itself to capitalize on the growing demand for CBD.

You can read the entire 5-minute guide from The Motley Fool here.

Learn more about Medical Marijuana, Inc. and its portfolio of companies by visiting our news feed. Current shareholders can find the latest investor information on our investors page.